Background: Nestin is a type VI intermediate fi lament protein known as a marker for progenitor cells that can be mostly found in tissues during the embryonic and fetal periods. In our study, we aimed to determine the expression of nestin in meninges covering the brain tissue at different developmental stages and in the new born. Methods: In this study 10 human fetuses in different development stages between developmental weeks 9-34 and a newborn brain tissue were used. Fetuses in paraffi n section were stained with H+E and nestin immunohistochemical staining protocol was performed. Results: In this study, in the human meninges intense nestin expression was detected as early as in the 9th week of development. Intensity of this expression gradually decreased in later stages of development and nestin expression still persisted in a small population of newborn meningeal cells.
The human meninges perform many functions in the developing and adult human central nervous system (CNS) and are composed of a number of different cell types. The meninges exert structural and functional heterogeneity even though grouped together. They appear early during human development and originate from paraxial mesenchyme. Meningeal mesenchyme derived from neural crest cells initially forms a cellular network between the brain and skin that is without discriminating features (1, 2 ) . The fi rst meninges appeared as two mesenchymal condensations in the head area of early human embryos. The two condensations differentiate into parts of the head skeleton, as well as into the dura mater and the underlying leptomeninges (arachnoid and pia mater), might have proliferation potential during development such as stem cells, during the development (3). These two mesenchymal condensations in the development of the meninges subsequently differentiated into two different tissue components: connective tissue internally, dense in the dura mater and loose in the leptomeninges, and the epithelial component on the surface of the meninges. The epithelial components appeared as a result of mesenchymal to epithelial transformation (4) . This process in the cells of mesenchymal tissue was characterized by the replacement of mesenchymal proteins with the epithelial proteins and appearance of the typical basement membrane underlying epithelium (5) .
The meninges control some aspects of cortical neurogenesis and neuronal migration (6, 7) . Meninges in the brain and spinal cord may also directly harbor stem cells under basal conditions (8) and in response to insults, such as stroke and spinal cord injury (9, 10) . Thus, the meninges regulate the development of the brain and may also harbor stem cells in adult brain.
Nestin is an intermediate fi lament protein expressed during the developmental stages in a variety of embryonic and fetal tissues (11) . The functional signifi cance of nestin expression has not been fully elucidated (12) . Nestin was fi rst identifi ed in mitotically active central and peripheral nervous system stem/progenitor cells that give rise to both neurons and glia during early neurogenesis (13, 14) . It is also detected in some adult stem/progenitor cells; such as newborn vascular endothelial cells (15) (16) (17) , striated muscle precursor cell (18) , hair follicle precursor cell (19) , islet precursor cell (20) and liver oval cell (21) . Nestin may represent the proliferation, migration and multi-differentiated characteristics of multi-lineage progenitor cells (11) . Due to its characteristic expression pattern, nestin is generally considered as a marker of stem cells or progenitor cells (22) .
A possible role was ascribed to nestin in growing CNS, especially in neuroepithelial stem cells and gliomas in previous studies on human tissues and in experimental animals (23, 24) . The aim of this study was to analyze nestin expression in embryonic, fetal and postnatal human meninges.
Methods

Tissues and HE staining
In the current study, a total of 10 human concepti between developmental weeks 9 and newborn were collected after spontaneous abortions from Department of Pathology, University of Erciyes, Faculty of Medicine (Tab.1). This study was approved by the Institutional Research Ethics Committee and adhered to Declaration of Helsinki guidelines (25) .
The head areas of embryo and fetus were fi xed in 10 % formaldehyde for 24 hours followed by dehydration through a graded ethanol series. These samples were made transparent in xylol and embedded in paraffi n wax. Sections in 5 μm thickness obtained from samples were transferred to slides covered with poly-L-lysine to prevent detachment. Every section was stained with hematoxylin-eosin to determine the morphological appearance of each part of the meninges in this section.
Nestin immunohistochemistry
Sections of 5 μm thick were obtained with microtom and were put on poly-L-lysine slides, and immunohistochemical procedures were applied after completion of the deparaffi nization and rehydration stages. Immunohistochemistry was performed by using the avidin-biotin-peroxidase method and applied using a streptavidin-biotin kit. Briefl y, each tissue section was deparaffi nized, rehydrated and then incubated with 3 % fresh hydrogen peroxide (H 2 O 2 ) in methanol for 10 min. After rinsing with phosp- hate-buffered saline (PBS), antigen retrieval was carried out by microwave treatment in 0.01 M sodium citrate buffer (pH 6.0) at 100 °C for 15 min. Next, non-specifi c binding was blocked with normal goat serum for 15 min at room temperature, followed by incubation with monoclonal Mouse anti-human nestin antibody (Rb X nestin, AB 5922, Millipore, fi nal dilution 1:200) overnight at 4 °C. After rinsing with PBS, the slides were incubated for 10 min at room temperature with biotin-conjugated secondary antibodies, followed by incubation with streptavidin-conjugated peroxidase working solution for 10 min. Subsequently, sections were stained for 10 min with 3,3'-diaminobenzidine tetrahydrochloride (DAB), counterstained with Mayer's hematoxylin, dehydrated and mounted. Negative controls were prepared by substituting PBS for primary antibody. All applications were performed at room temperature in a moist ambient to prevent samples from drying. The prepared samples were inspected by Olympus BX51 microscopy (Olympus, Tokyo, Japan).
Quantitative immunohistochemistry
In total, 10 samples were stained with nestin. Different reference areas (per visual fi elds) from fetuses were randomly defi ned and then analysis was performed on sections. The programs of Image J software and Graph Pad Prism were used to evaluate immune-reactivity intensity of nestin.
Results
Mesenchymal cell intensity covered 9 weeks, early embryonic process, brain tissue and the area that meninges will be developing from were evident. At this stage stratums have not been distinguished in the brain cortex (Fig. 1a) . During early human development, layer distinguished in cortex is stratum moleculare, the nearest to cortex surface. Developed meninges were placed on this layer and covered all brain surface (Fig. 1b, c) . Towards the end of the fetal life, brain tissue was similar to adult brain tissue with its neurons and other stratums. The molecular layer, the nearest to stratum moleculare surface of brain cortex was quite evident and had similar features to adult meninges (Fig. 1d) .
Nestin expressed in progenitor cells during embryonic and fetal process was found in human meninges as early as in the 9th week of development (Fig. 2a) . Its expression fi rstly increased during embryonic and early fetal periods. The gradually decreasing expression seen in mezenchymal condensation depends on fetal developing in area of the developing meninges (Fig. 2b, c, d ). In later stages of fetal development, nestin positive cell populations were detected to be decreased in this area (Fig. 3a) . Even during the postpartum period, nestin expression was negative in the most of the area of meninges, while weak expression of nestin was observed in some meningeal cells (Fig.  3b) . Nestin expression in meninges of fetuses in different stages of development gradually decreased in progression of differentation. When this groups were compared in terms of intensity of nestin expression, gradual decrease of nestin expression was statistically signifi cant depending on the progression of fetal development (Fig. 3c) .
Discussion
Recently, the intermediate fi lament proteins were shown to have important roles in cell division, proliferation and migration through participating in cytoplasmic transport. The change mechanism of the intracellular organisations is still not fully understood in various situations such as mitosis, differentiation and different pathological conditions of dynamic structure of intermediate fi lament proteins (26, 27) . The word nestin is an acronym of neuroepithelial stem cell protein (28) and it is a type VI intermediate fi lament protein forming bundles in neuroepithelial stem/progenitor cells in the growing central nervous system of rat embryos and in humans (20, 30) . Nestin was expressed mostly in the progenitor cells of developing and innovating tissues in early periods of neural development and in CNS stem cells. Nestin was fi rstly identifi ed by immunohistochemistry (13) . Nestin expression in adult tissues was attributed to stem cell and progenitor cell populations. It was postulated that these progenitor cells are reactivated and proliferate and migrate in response to injury during tissue regeneration (30) . The studies on human tissues and experimental animals revealed that nestin was highly expressed in neuroepithelial stem cells in CNS development and in gliomas (31, 32) . Recently, nestin was shown to be expressed in progenitor cells of developing human spinal ganglia (33) and optic nerve (34) . Nestin was detected in neuronal precursor cells, developing skeletal and cardiac musle cells, mesonephric mesenchyme, pancreatic progenitor cells and vascular endothelium, among others (30) . Nestin expression in those cells subsequently decreased at later developmental stages and fi nally disappeared in terminally differentiated and mature cells (33, 34) . Nestin expression was thought to be transient in these progenitor cells and differentiation in specialized cells types resulted in down-regulation of nestin and expression of other cells type-specifi c intermediate fi laments, like neurofi laments in neurons (35) .
Nestin expression in rat leptomeningeal cells was found at different developmental stages, however, gradually diminished in later fetal development and in the newborn (23) . Nestin was temporarily expressed in multipotent neuroepithelial stem cells during embryonic development (36) . Similar to these fi ndings, in the present study, we detected nestin expression as early as in the 9th developmental week in human meninges and then it gra- dually decreased in later fetal development and after birth. In our study, according to the pattern of nestin expression in developing meninges, nestin may be demonstrated as a possible marker of immature cells during early development and later development stages. The cells expressing nestin represented immature cells which subsequently diminished during development of meninges, however still remained in a small population of normal meningeal cells after birth. The identity of intermediate fi lament proteins in human meninges is incompletely understood. Their role is not established in pathologies, such as meningiomas, meningeal carcinomatosis or meningitis. In conclusion, nestin expression in immature meningeal cells of ectodermal origin was present both, during development process and after the birth. Nestin positive cells during maturation and development of meninges subsequently diminished, however, still remained in a small meningeal cells population in newborn brain tissue. This probably depends on decreased nestin expression and replacement with other tissuespesifi c intermediate fi lament proteins with advancing development. We speculate that these differences may have a signifi cant contribution in the areas of investigation and diagnosis of various pathological disorders.
